Skip to search formSkip to main contentSkip to account menu

Paroxetine

Known as: (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine, Paroxetine [Chemical/Ingredient], (-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine 
A serotonin uptake inhibitor that is effective in the treatment of depression.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
BACKGROUND Tamoxifen, a selective estrogen receptor modulator (SERM), is converted to 4-hydroxy-tamoxifen and other active… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND & AIMS Psychotherapy and antidepressants are effective in patients with severe irritable bowel syndrome (IBS), but the… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with… 
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To compare paroxetine with placebo and imipramine with placebo for the treatment of adolescent depression. METHOD… 
Highly Cited
2001
Highly Cited
2001
OBJECTIVE Depression is commonly associated with frontal hypometabolic activity accompanied by hypermetabolism in certain limbic… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND In functional brain imaging studies of major depressive disorder (MDD), regional abnormalities have been most commonly… 
Highly Cited
2001
Highly Cited
2001
OBJECTIVE This study evaluated the efficacy and safety of paroxetine for the treatment of patients with chronic posttraumatic… 
Review
1999
Review
1999